Frequency and determinants of using pharmacological enhancement in the clinical practice of in-hospital stroke rehabilitation

European Neurology

Volumn 68, Issue 1, 2012, Pages 28-33

  Engelter, Stefan T ^a,b   Urscheler, Niklaus ^c   Baronti, Fabio ^d   Vuadens, Philippe ^e   Koch, Joachim ^f   Frank, Matthias ^a   Disserens, Karin ^g   Jenni, Walter ^f  

^a Felix Platter Spital   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c Reha Rheinfelden   (Switzerland)

^d Klinik Bethesda Tschugg   (Switzerland)

^e Clinique Romande de Radaptation   (Switzerland)

^f Rehazentrum Leukerbad ^*  (Switzerland)

^g LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

In hospital stroke rehabilitation; PESR utilization rates; Pharmacological enhancement

Indexed keywords

CHOLINESTERASE INHIBITOR; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; MEMANTINE; METHYLPHENIDATE; MODAFINIL; PIRACETAM; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

APHASIA; ARTICLE; CLINICAL PRACTICE; CONVALESCENCE; DEPRESSION; DRUG USE; HOSPITAL CARE; PARESIS; PHARMACEUTICAL CARE; PRIORITY JOURNAL; REHABILITATION CARE; REHABILITATION CENTER; STROKE;

AGED; FEMALE; HUMANS; MALE; PHYSICIAN'S PRACTICE PATTERNS; RECOVERY OF FUNCTION; STROKE;

EID: 84861809159     PISSN: 00143022     EISSN: 14219913     Source Type: Journal    
DOI: 10.1159/000335895     Document Type: Article

References (33)

1. Duffau H: Brain plasticity: from pathophysi-ological mechanisms to therapeutic applica-tions. J Clin Neurosci 2006; 13: 885-897. (Pubitemid 44666418)
2. Rösser N, Flöel A: Pharmacological en-hancement of motor recovery in subacute and chronic stroke. NeuroRehabilitation 2008; 23: 95-103. (Pubitemid 352038566)
3. Chollet F, Tardy J, Albucher JF, Thalamas C, Berard E, Lamy C, Bejot Y, Deltour S, Jaillard A, Niclot P, Guillon B, Moulin T, Marque P, Pariente J, Arnaud C, Loubinoux I: Fluox-etine for motor recovery after acute isch-aemic stroke (FLAME): a randomised place-bo-controlled trial. Lancet Neurol 2011; 10: 123-130.
4. Scheidtmann K, Fries W, Muller F, Koenig E: Effect of levodopa in combination with phys-iotherapy on functional motor recovery after stroke: a prospective, randomised, double-blind study. Lancet 2001; 358: 787-790. (Pubitemid 32868727)
5. Rösser N, Heuschmann P, Wersching H, Breitenstein C, Knecht S, Flöel A: Levodopa improves procedural motor learning in chronic stroke patients. Arch Phys Med Re-habil 2008; 89:1633-1641.
6. Bragoni M, Altieri M, Di Piero, V, Padovani A, Mostardini C, Lenzi GL: Bromocriptine and speech therapy in non-fluent chronic aphasia after stroke. Neurol Sci 2000; 21: 19-22. (Pubitemid 30430854)
7. Berthier ML, Green C, Higueras C, Fernan-dez I, Hinojosa J, Martin MC: A randomized, placebo-controlled study of donepezil in poststroke aphasia. Neurology 2006; 67: 1687-1689. (Pubitemid 44747948)
8. Whyte EM, Lenze EJ, Butters M, Skidmore E, Koenig K, Dew MA, Penrod L, Mulsant BH, Pollock BG, Cabacungan L, Reynolds CF III, Munin MC: An open-label pilot study of ace-tylcholinesterase inhibitors to promote functional recovery in elderly cognitively impaired stroke patients. Cerebrovasc Dis 2008; 26: 317-321.
9. Kessler J, Thiel A, Karbe H, Heiss WD: Pi-racetam improves activated blood flow and facilitates rehabilitation of poststroke apha-sic patients. Stroke 2000; 31:2112-2116.
10. Grade C, Redford B, Chrostowski J, Tous-saint L, Blackwell B: Methylphenidate in ear-ly poststroke recovery: a double-blind, place-bo-controlled study. Arch Phys Med Rehabil 1998; 79: 1047-1050. (Pubitemid 28419310)
11. Czlonkowska A, Lesniak M: Pharmacother-apy in stroke rehabilitation. Expert Opin Pharmacother 2009; 10:1249-1259.
12. Robinson RG, Adams HP: Selective sero-tonin-reuptake inhibitors and recovery after stroke. Lancet Neurol 2011; 10:110-111.
13. Greener J, Enderby P, Whurr R: Pharma-cological treatment for aphasia following stroke. Cochrane Database Syst Rev 2001; (4):CD000424.
14. Ashtary F, Janghorbani M, Chitsaz A, Reisi M, Bahrami A: A randomized, double-blind trial of bromocriptine efficacy in nonfluent aphasia after stroke. Neurology 2006; 66: 914-916.
15. Sonde L, Lokk J: Effects of amphetamine and/or L -dopa and physiotherapy after stroke - a blinded randomized study. Acta Neurol Scand 2007; 115:55-59. (Pubitemid 44915499)
16. Laska AC, von AM, Kahan T, Hellblom A, Murray V: Long-term antidepressant treat-ment with moclobemide for aphasia in acute stroke patients: a randomised, double-blind, placebo-controlled study. Cerebrovasc Dis 2005; 19: 125-132. (Pubitemid 40278672)
17. Martinsson L, Eksborg S, Wahlgren NG: In-tensive early physiotherapy combined with dexamphetamine treatment in severe stroke: a randomized, controlled pilot study. Cere-brovasc Dis 2003; 16:338-345. (Pubitemid 37140422)
18. Restemeyer C, Weiller C, Liepert J: No effect of a levodopa single dose on motor perfor-mance and motor excitability in chronic stroke. A double-blind placebo-controlled cross-over pilot study. Restor Neurol Neuro-sci 2007; 25:143-150. (Pubitemid 47290442)
19. Cramer SC, Dobkin BH, Noser EA, Rodri-guez RW, Enney LA: Randomized, placebo-controlled, double-blind study of ropinirole in chronic stroke. Stroke 2009; 40: 3034-3038.
20. Sprigg N, Bath PM: Speeding stroke recov-ery? A systematic review of amphetamine af-ter stroke. J Neurol Sci 2009; 285:3-9.
21. Martinsson L, Hardemark H, Eksborg S: Amphetamines for improving recovery after stroke. Cochrane Database Syst Rev 2007;CD002090.
22. Engelter ST, Frank M, Lyrer PA, Conzel-mann M: Safety of pharmacological aug-mentation of stroke rehabilitation. Eur Neu-rol 2010; 64:325-330.
23. Liepert J: Pharmacotherapy in restorative neurology. Curr Opin Neurol 2008; 21:639-643.
24. Zittel S, Weiller C, Liepert J: Citalopram im-proves dexterity in chronic stroke patients. Neurorehabil Neural Repair 2008; 22:311-314. (Pubitemid 351561669)
25. Jorge RE, Acion L, Moser D, Adams HP Jr, Robinson RG: Escitalopram and enhance-ment of cognitive recovery following stroke. Arch Gen Psychiatry 2010; 67: 187-196.
26. Zittel S, Weiller C, Liepert J: Reboxetine im-proves motor function in chronic stroke. A pilot study. J Neurol 2007; 254: 197-201. (Pubitemid 46356052)
27. Brioschi A, Gramigna S, Werth E, Staub F, Ruffieux C, Bassetti C, Schluep M, Annoni JM: Effect of modafinil on subjective fatigue in multiple sclerosis and stroke patients. Eur Neurol 2009; 62: 243-249.
28. Delbari A, Salman-Roghani R, Lokk J: Effect of methylphenidate and/or levodopa com-bined with physiotherapy on mood and cog-nition after stroke: a randomized, double-blind, placebo-controlled trial. Eur Neurol 2011; 66:7-13.
29. Culmsee C, Junker V, Kremers W, Thal S, Plesnila N, Krieglstein J: Combination ther-apy in ischemic stroke: synergistic neuropro-tective effects of memantine and clenbuterol. Stroke 2004; 35: 1197-1202. (Pubitemid 38543543)
30. Paolucci S: Epidemiology and treatment of post-stroke depression. Neuropsychiatr Dis Treat 2008; 4:145-154. (Pubitemid 351460985)
31. Robinson RG, Jorge RE, Moser DJ, Acion L, Solodkin A, Small SL, Fonzetti P, Hegel M, Arndt S: Escitalopram and problem-solving therapy for prevention of poststroke depres-sion: a randomized controlled trial. JAMA 2008; 299:2391-2400. (Pubitemid 351749237)
32. Flöel A, Hummel F, Breitenstein C, Knecht S, Cohen LG: Dopaminergic effects on encod-ing of a motor memory in chronic stroke. Neurology 2005; 65:472-474. (Pubitemid 41099818)
33. Goldstein LB: Potential effects of common drugs on stroke recovery. Arch Neurol 1998; 55:454-456. (Pubitemid 28182689)